Your browser doesn't support javascript.
loading
Glb1 knockout mouse model shares natural history with type II GM1 gangliosidosis patients.
Nicoli, Elena-Raluca; Huebecker, Mylene; Han, Sangwoo T; Garcia, Karolyn; Munasinghe, Jeeva; Lizak, Martin; Latour, Yvonne; Yoon, Robin; Glase, Brianna; Tyrlik, Michal; Peiravi, Morteza; Springer, Danielle; Baker, Eva H; Priestman, David; Sidhu, Rohini; Kell, Pamela; Jiang, Xuntian; Kolstad, Josephine; Kuhn, Anna Luisa; Shazeeb, Mohammed Salman; Acosta, Maria T; Proia, Richard L; Platt, Frances M; Tifft, Cynthia J.
Afiliação
  • Nicoli ER; Glycosphingolipid and Glycoprotein Disorders Unit, Medical Genetic Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States.
  • Huebecker M; Department of Pharmacology, University of Oxford, Oxford, United Kingdom.
  • Han ST; Glycosphingolipid and Glycoprotein Disorders Unit, Medical Genetic Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States.
  • Garcia K; Glycosphingolipid and Glycoprotein Disorders Unit, Medical Genetic Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States.
  • Munasinghe J; Mouse Imaging Facility, National Institute of Neurological Disorder and Stroke, National Institutes of Health, Bethesda, MD, United States.
  • Lizak M; Mouse Imaging Facility, National Institute of Neurological Disorder and Stroke, National Institutes of Health, Bethesda, MD, United States.
  • Latour Y; Glycosphingolipid and Glycoprotein Disorders Unit, Medical Genetic Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States.
  • Yoon R; Glycosphingolipid and Glycoprotein Disorders Unit, Medical Genetic Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States.
  • Glase B; Glycosphingolipid and Glycoprotein Disorders Unit, Medical Genetic Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States.
  • Tyrlik M; Glycosphingolipid and Glycoprotein Disorders Unit, Medical Genetic Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States; Phenotyping Core (D.A.S.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United S
  • Peiravi M; Phenotyping Core (D.A.S.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States.
  • Springer D; Phenotyping Core (D.A.S.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States.
  • Baker EH; Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD, United States.
  • Priestman D; Department of Pharmacology, University of Oxford, Oxford, United Kingdom.
  • Sidhu R; Department of Medicine, Washington University School of Medicine, Saint Louis, MO, United States.
  • Kell P; Department of Medicine, Washington University School of Medicine, Saint Louis, MO, United States.
  • Jiang X; Department of Medicine, Washington University School of Medicine, Saint Louis, MO, United States.
  • Kolstad J; Image Processing and Analysis Core (iPAC), Department of Radiology, UMass Chan Medical School, Worcester, MA, United States.
  • Kuhn AL; Image Processing and Analysis Core (iPAC), Department of Radiology, UMass Chan Medical School, Worcester, MA, United States.
  • Shazeeb MS; Image Processing and Analysis Core (iPAC), Department of Radiology, UMass Chan Medical School, Worcester, MA, United States.
  • Acosta MT; Undiagnosed Diseases Program, Common Fund, Office of the Director, National Institutes of Health, Bethesda, MD, United States.
  • Proia RL; Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, United States.
  • Platt FM; Department of Pharmacology, University of Oxford, Oxford, United Kingdom.
  • Tifft CJ; Glycosphingolipid and Glycoprotein Disorders Unit, Medical Genetic Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States; Undiagnosed Diseases Program, Common Fund, Office of the Director, National Institutes of Health, Bethesda, MD, United Stat
Mol Genet Metab ; 138(2): 107508, 2023 02.
Article em En | MEDLINE | ID: mdl-36709532
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças por Armazenamento dos Lisossomos / Gangliosidose GM1 Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças por Armazenamento dos Lisossomos / Gangliosidose GM1 Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article